The treatment developed by the pharmaceutical group AstraZeneca is called osimertinib and is marketed under the name Tagrisso.

It's easy, too, to finger "radical Islam," and its international sponsors, such as Saudi Arabia, for the exponential rise in intolerance.

A BILL to give effect to the financial proposals of the Central Government for the financial year 2011-2012. Be it enacted by Parliament in...